v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (6,369,652) $ (4,517,259)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 650,024 371,472
Restricted stock issued for consulting expense 43,651
Change in fair value of warrant liability (254,955) (825,989)
Change in operating assets and liabilities:    
Prepaid expenses and other current assets 137,114 (456,752)
Accounts payable 940,877 359,070
Accrued expenses (458,387) 867,184
Net cash used in operating activities (5,311,328) (4,202,274)
Cash flows from financing activities:    
Proceeds from exercise of stock options 38,549 844
Proceeds from confidentially marketed public offering 33,008,813
Proceeds from At-The-Market offering 1,521,091
Payment of offering transactions costs (1,995,041) (204,668)
Net cash provided by financing activities 31,052,321 5,461,216
Net effect of foreign currency exchange on cash 14,086 3,056
Net increase in cash 25,755,079 1,261,998
Cash at beginning of period 8,658,031 9,601,298
Cash at end of period 34,413,110 10,863,296
Supplemental disclosure of cash flow information:    
Warrants issued in connection with private placement offering 1 2025 1,107,202
Warrants issued in connection with private placement offering 2 2025 571,566
Private Placement Offering One 2025 [Member]    
Cash flows from financing activities:    
Proceeds from private placement 2,715,000
Private Placement Offering Two 2025 [Member]    
Cash flows from financing activities:    
Proceeds from private placement $ 1,428,949